Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Karen Reckamp

Cedars-Sinai Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (13)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (9)

Stephen Liu

Associate Professor

Georgetown University School of Medicine

UNITED STATES

View details

Christopher Lieu

Associate Professor

University of Denver

UNITED STATES

View details

Lisa McShane

Associate Director, Division of Cancer Treatment & Diagnosis

National Cancer Institute

UNITED STATES

View details

Mark Burkard

Director, Holden Comprehensive Cancer Center; Associate Dean of Cancer Research

University of Wisconsin-Madison

UNITED STATES

View details

Ryan Gentzler

University of Virginia

UNITED STATES

View details

Hossein Borghaei

Professor and Chief, Thoracic Oncology

Fox Chase Cancer Center

UNITED STATES

View details

Tejas Patil

Assistant Professor

University of Colorado School of Medicine

UNITED STATES

View details

YASIR ELAMIN

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Nicole Simone

Professor; Program Leader SKCC; Vice Chair for Research, Faculty Development and DEI

Sidney Kimmel Medical College at Thomas Jefferson University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karen Reckamp

Research Interests

Explore related searches

Articles (13)

The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective

Circulating Inflammatory and Mitochondrial Biomarkers Associated with Cachexia in Advanced Non-Small Cell Lung Cancer

Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 ( NRG1 ) Fusions

The Expanding Landscape of Next-Generation EGFR Tyrosine Kinase Inhibitors: Have We Reached Capacity?

An evaluation of patritumab deruxtecan for the treatment of EGFR -mutated non-small cell lung cancer

DNA damage repair gene alterations influence the tumor immune microenvironment in advanced non-small cell lung cancer

A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol

Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A

Emerging Targets in Non-Small Cell Lung Cancer

Pragmaticism in Cancer Clinical Trials

Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non–Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175

Moving Toward Rationale Phase 3 Designs for Advanced NSCLC

Collaborators (9)

Stephen Liu

Christopher Lieu

Lisa McShane

Mark Burkard

Ryan Gentzler

Hossein Borghaei

Tejas Patil

YASIR ELAMIN

Nicole Simone

Make your next move.